Navigation Links
Maryland Stem Cell Commission Issues Nationwide Request for Applications for New Post-Doctoral Fellowship Grants

COLUMBIA, Md., Dec. 17 /PRNewswire/ -- The Maryland Stem Cell Research Commission (Commission) today issued a Request for Applications (RFA) for new post-doctoral fellowship grants under RFA-MD-07-3. The Commission is soliciting nationwide applications from pre-doctoral students and post- doctoral fellows who wish to conduct basic and/or translational research on all types of human stem cells in Maryland.

It is estimated that up to 16 fellowships will be funded with each fellowship being awarded up to $55,000 per year for up to two years, which is inclusive of all direct, indirect and fringe benefits costs. Maryland-based organizations of all types are eligible as training institutes, including public and private, for-profit and non-profit, universities, colleges, research institutes, companies, medical centers, and others.

The Commission's goal in creating these fellowship grants is to grow the biotechnology community in Maryland by training the next generation of stem cell researchers. This addresses a purpose of the Maryland Research Stem Cell Act, which is to broaden and advance basic knowledge of human stem cell biology that will be relevant for eventual development of clinical applications, and to enable, support and accelerate such clinical applications for prevention, diagnosis and treatment of human diseases and conditions.

Applications for the fellowship should follow the guideline under the RFA- MD-07-3, and must be submitted electronically to TEDCO at by 5 p.m. EST on Thursday, Jan. 31, 2008.

Applications will be evaluated based on the following: the applicant's qualifications and potential for stem cell research, the quality of the proposed training program, the mentor's qualifications and training record, the training environment, and the applicant's relevance to stem cell research. Applicants will be evaluated by an independent peer review committee comprised of scientifically recognized experts in the field of stem cell research that reside out of the State.

Questions by applicants about this RFA may only be addressed by email at More information about RFA-MD-07-3 requirements and the Maryland Stem Cell Research Fund can be found at

SOURCE The Maryland Stem Cell Research Commission
Copyright©2007 PR Newswire.
All rights reserved

Related biology technology :

1. BioSpace Career Fair in Bethesda, Maryland Draws Hundreds of Industry Professionals
2. Federal Trade Commission Clears Kyphons Acquisition of Non-Vertebroplasty Spine-Related Assets of Disc-O-Tech
3. Enigma Diagnostics Announces a European Commission Award of EUR3 Million to Fund the Development of a Point of Care Platform for the Rapid Diagnosis of Influenza Infections
4. Schering-Plough Receives Approval from European Commission for Planned Acquisition of Organon BioSciences N.V.
5. Poniard Pharmaceuticals Announces European Commission Grants Orphan Medicinal Product Designation to Picoplatin for Treatment of Small Cell Lung Cancer
6. Pharmos Issues Letter to Shareholders
7. MichBio Issues 2007/8 Michigan Life Sciences Directory and Resources Guide
8. HHS Issues First Department-Wide Report on Personalized Health Care
9. CalbaTech Issues Update; Beginning Training for Adult Stem Cell Collections in Atlanta
10. Symmetry Medical Discloses Accounting Issues at Sheffield, UK Operating Unit and Possible Restatement
11. CCPM Issues Statement on FDAs GIVE Initiative
Post Your Comments:
(Date:11/26/2015)... MUMBAI , November 26, 2015 ... --> Accutest Research ... accredited Contract Research Organization (CRO), has ... Chase Cancer Center - Temple Health ... ,     (Photo: ) ...
(Date:11/25/2015)... Md. , Nov. 25, 2015  PharmAthene, Inc. ... Directors has adopted a stockholder rights plan (Rights Plan) ... net operating loss carryforwards (NOLs) under Section 382 of ... --> PharmAthene,s use of its NOLs ... "ownership change" as defined in Section 382 of the ...
(Date:11/25/2015)... LOS ANGELES and HOLLISTON, Mass. ... Regenerative Technology, Inc. (Nasdaq: HART ), a biotechnology ... announced that CEO Jim McGorry will present ... Tuesday, December 1, 2015 at 2:30 p.m. PT. The ... (link below) for 30 days. Management will also be ...
(Date:11/25/2015)... ... 25, 2015 , ... A long-standing partnership between the Academy ... been formalized with the signing of a Memorandum of Understanding. , AMA Executive ... Karl Minter and Capt. Albert Glenn Tuesday, November 24, 2015, at AMA Headquarters ...
Breaking Biology Technology:
(Date:11/4/2015)... ALBANY, New York , November 4, 2015 /PRNewswire/ ... According to a new market report published by Transparency ... Size, Share, Growth, Trends and Forecast 2015 - 2022", ... value of US$ 30.3 bn by 2022. The market ... during the forecast period from 2015 to 2022. Rising ...
(Date:10/29/2015)... LA JOLLA, Calif. , Oct. 29, 2015 /PRNewswire-USNewswire/ ... released a new report titled, "DNA Synthesis and Biosecurity: ... how well the Department of Health and Human Services ... was issued in 2010. --> ... advances, but it also has the potential to pose ...
(Date:10/29/2015)... health pioneer, Joseph C. Kvedar , MD, describes ... wellness, and the business opportunities that arise from it ... Healthy Things . Long before health and wellness ... vice president, Connected Health, Partners HealthCare, was creating a ... the hospital or doctor,s office into the day-to-day lives ...
Breaking Biology News(10 mins):